Literature DB >> 26352895

Renal cell carcinoma in patients with a personal or family history of hematologic malignancies.

Janice P Dutcher1, Peter H Wiernik2.   

Abstract

A little-appreciated association between renal cell carcinoma (RCC) and hematologic malignancies (HMs) has been reported for at least 20 years. The HM characteristically occurs first in patients with both neoplasms, and the large majority (94%) of these HMs are of B-cell origin. Furthermore, the majority of patients with RCC and an HM are male. Recently, we have noted an increased incidence of HMs in families of patients with RCC and are exploring this observation further. Here, we summarize our reports on the association between these neoplasms in individual patients and review the relevant literature.

Entities:  

Mesh:

Year:  2015        PMID: 26352895

Source DB:  PubMed          Journal:  Clin Adv Hematol Oncol        ISSN: 1543-0790


  4 in total

1.  Case Report: New Onset Lymphadenopathy After Immune Checkpoint Inhibitor Therapy Presents a Clinicopathological and Radiological Challenge.

Authors:  Matthew Scarlotta; Robin Avery; Ezra Baraban; Zahra Maleki; Yasser Ged
Journal:  Front Oncol       Date:  2022-05-20       Impact factor: 5.738

2.  Occurrence of renal cell carcinoma and hematologic malignancies (predominantly lymphoid) in individuals and in families.

Authors:  Janice P Dutcher; Peter H Wiernik; Leticia Varella; Rangaswamy Chintapatla
Journal:  Fam Cancer       Date:  2016-10       Impact factor: 2.375

3.  A patient with Multiple myeloma and Renal cell carcinoma.

Authors:  Farhad Shahi; Marziye Ghalamkari; Mehrzad Mirzania; Mahdi Khatuni
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2016-01-01

4.  Chronic lymphocytic lymphoma and concomitant renal cell carcinoma (Clear Cell Type): Review of the literature.

Authors:  Burak Uz; Ilhan Dolasik; Ozlem Ucer; Adile Ferda Dagli; Sercan Simsek
Journal:  Leuk Res Rep       Date:  2016-06-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.